Cargando…
Sotrovimab in pediatric cardiac transplant recipients with SARS-CoV2 infection
Autores principales: | Weber, Sven C., Danne, Friederike, Kieslich, Moritz, Krauss, Annemarie, Berger, Felix, Sallmon, Hannes |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Society for Heart and Lung Transplantation.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9119718/ https://www.ncbi.nlm.nih.gov/pubmed/35697603 http://dx.doi.org/10.1016/j.healun.2022.05.003 |
Ejemplares similares
-
Kinetics of cellular and humoral responses to third COVID-19 vaccine in heart transplant recipients: Correspondence
por: Sokaromdee, Pathum, et al.
Publicado: (2022) -
Paucisymptomatic COVID-19 in lung transplant recipient following two doses of mRNA-1273 (Moderna) vaccine
por: Marinelli, Tina, et al.
Publicado: (2021) -
First lung and kidney multi-organ transplant following COVID-19 Infection
por: Guenthart, Brandon A., et al.
Publicado: (2021) -
Successful lung transplantation in COVID-19 PCR positive patients: A single-center experience
por: Natori, Yoichiro, et al.
Publicado: (2023) -
Careful clinical evaluation of donor fraction cell-free DNA in rejection surveillance after heart transplantation
por: Napoli, Claudio, et al.
Publicado: (2020)